Hepion Pharmaceuticals Inc (HEPA)
1.10
+0.04
(+3.77%)
USD |
NASDAQ |
Jun 27, 16:00
1.09
-0.01
(-0.91%)
After-Hours: 20:00
Hepion Pharmaceuticals Free Cash Flow: -36.29M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -36.29M |
| December 31, 2023 | -40.90M |
| September 30, 2023 | -36.70M |
| June 30, 2023 | -38.00M |
| March 31, 2023 | -33.05M |
| December 31, 2022 | -34.96M |
| September 30, 2022 | -37.55M |
| June 30, 2022 | -36.37M |
| March 31, 2022 | -34.05M |
| December 31, 2021 | -31.35M |
| September 30, 2021 | -28.57M |
| June 30, 2021 | -21.07M |
| March 31, 2021 | -19.01M |
| December 31, 2020 | -16.25M |
| September 30, 2020 | -14.10M |
| June 30, 2020 | -12.05M |
| March 31, 2020 | -10.20M |
| December 31, 2019 | -7.616M |
| September 30, 2019 | -10.26M |
| June 30, 2019 | -12.00M |
| Date | Value |
|---|---|
| March 31, 2019 | -14.15M |
| December 31, 2018 | -15.65M |
| September 30, 2018 | -15.93M |
| June 30, 2018 | -16.63M |
| March 31, 2018 | -18.42M |
| September 30, 2017 | -20.18M |
| June 30, 2017 | -19.19M |
| March 31, 2017 | -19.33M |
| December 31, 2016 | -18.00M |
| September 30, 2016 | -18.13M |
| June 30, 2016 | -16.56M |
| March 31, 2016 | -16.51M |
| December 31, 2015 | -15.52M |
| September 30, 2015 | -11.48M |
| June 30, 2015 | -9.756M |
| March 31, 2015 | -6.109M |
| December 31, 2014 | -3.572M |
| September 30, 2014 | -2.291M |
| June 30, 2014 | -1.363M |
Free Cash Flow Range, Past 5 Years
-40.90M
Minimum
Dec 2023
-7.616M
Maximum
Dec 2019
-25.52M
Average
-29.96M
Median
Free Cash Flow Benchmarks
| Bio-Path Holdings Inc | -8.92M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.617M |
| Cash from Financing (Quarterly) | 1.850M |
| Free Cash Flow Per Share (Quarterly) | -0.713 |
| Free Cash Flow Yield | -769.8% |